Found: 11
Select item for more details and to access through your institution.
The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 7, p. 1845, doi. 10.1007/s00432-019-02918-y
- By:
- Publication type:
- Article
Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 153, n. 1, p. 31, doi. 10.1007/s10549-015-3516-y
- By:
- Publication type:
- Article
Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 128, n. 3, p. 713, doi. 10.1007/s10549-010-1058-x
- By:
- Publication type:
- Article
VAV3 mediates resistance to breast cancer endocrine therapy.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 3, p. 1, doi. 10.1186/bcr3664
- By:
- Publication type:
- Article
VAV3 mediates resistance to breast cancer endocrine therapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials.
- Published in:
- Breast Cancer Research, 2013, v. 15, n. 5, p. 2, doi. 10.1186/bcr3557
- By:
- Publication type:
- Article
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials.
- Published in:
- 2013
- By:
- Publication type:
- journal article
High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
- Published in:
- Genes, Chromosomes & Cancer, 2011, v. 50, n. 10, p. 775, doi. 10.1002/gcc.20900
- By:
- Publication type:
- Article
GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00688-6
- By:
- Publication type:
- Article
ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2-positive metastatic breast cancer treated with trastuzumab.
- Published in:
- Oncology Letters, 2019, v. 17, n. 3, p. 3371
- By:
- Publication type:
- Article
IP6K2 predicts favorable clinical outcome of primary breast cancer.
- Published in:
- Molecular & Clinical Oncology, 2021, v. 14, n. 5, p. N.PAG, doi. 10.3892/mco.2021.2256
- By:
- Publication type:
- Article